journal
Journals International Clinical Psychop...

International Clinical Psychopharmacology

https://read.qxmd.com/read/37159165/dress-syndrome-quetiapine-associated-case-report-and-literature-review
#1
JOURNAL ARTICLE
Hannah L Mallaro, Lisa J Rosenthal
Drug rash with eosinophilia and systemic symptoms (DRESS syndrome) is a rare systemic adverse drug reaction with a high mortality rate. Cases of DRESS syndrome have been reported with almost all classes of psychiatric medications, but data remains limited. We describe the case of a 33-year-old woman who presented with acute respiratory distress syndrome secondary to severe pulmonary blastomycosis. Her hospital course was complicated by severe agitation for which the psychiatry consult team was involved and several medications were trialed including quetiapine...
May 8, 2023: International Clinical Psychopharmacology
https://read.qxmd.com/read/37159173/ketamine-for-depression-a-potential-role-in-requests-for-medical-aid-in-dying
#2
JOURNAL ARTICLE
Nicolas Garel, Michka Nazon, Kamran Naghi, Elena Willis, Karl Looper, Soham Rej, Kyle T Greenway
Medical Aid in Dying (MAiD) is the act of a healthcare provider ending a patient's life, at their request, due to unbearable suffering from a grievous and incurable disease. Access to MAiD has expanded in the last decade and, more recently, it has been made available for psychiatric illnesses in a few countries. Recent studies have found that such psychiatric requests are rapidly increasing and primarily involve mood disorders as the primary condition. Nevertheless, MAiD for psychiatric disorders is associated with significant controversy and debate, especially regarding the definition and determination of irremediability - that a given patient lacks any reasonable prospect for recovery...
April 18, 2023: International Clinical Psychopharmacology
https://read.qxmd.com/read/37159172/does-celecoxib-with-sodium-valproate-have-an-augmentation-effect-on-acute-mania-in-bipolar-disorder-a-double-blind-controlled-clinical-trial-in-iran
#3
JOURNAL ARTICLE
Farhad Faridhosseini, Ali Talaei, Najmeh Shahini, Zanireh Salimi, Mahboubeh Eslamzadeh, Samira Ahrari, Meysam Pourgholami, Majid Khadem-Rezaiyan
Inflammatory processes in the brain play a role in acute mania etiopathogenesis. There is little evidence indicating the efficacy of celecoxib adjuvant therapy in treatmenting of manic episodes of bipolar disorder. Therefore, this clinical trial aimed to assess the celecoxib effect on treating acute mania. In a double-blind, placebo-controlled trial, 58 patients meeting the criteria for acute mania were enrolled. After considering eligibility, 45 patients were included in the study and randomly divided into two groups...
April 12, 2023: International Clinical Psychopharmacology
https://read.qxmd.com/read/37159166/neuroscience-based-nomenclature-as-a-teaching-tool-introduction-and-pilot-study
#4
JOURNAL ARTICLE
Sasson Zemach, Daniel Minkin Levy, Joseph Zohar
Neuroscience-based nomenclature (NbN) is a pharmacologically-driven nomenclature aiming to replace the current disease-based nomenclature of psychotropics, focusing on pharmacology and mode-of-action to encourage scientifically-minded prescribing. NbN might also be used as a teaching tool as it presents the depth and richness of the neuroscience of psychotropics. This study examines the effect of using NbN in student curriculum. Fifty-six medical students during clerkship in psychiatry, divided into a control group (n = 20), taught standard psychopharmacology, and an intervention group (n = 36) introduced with NbN...
April 12, 2023: International Clinical Psychopharmacology
https://read.qxmd.com/read/36961017/age-or-age-of-onset-which-is-the-best-criterion-to-classify-late-life-depression
#5
JOURNAL ARTICLE
Paolo Olgiati, Giuseppe Fanelli, Alessandro Serretti
In late-life depression (LLD), several differences between patients whose first episode is reported after age 65 (late-onset depression, LOD) and those with early-onset depression (EOD) might reflect the effects of brain ageing. To test this hypothesis, we analysed the impact of current age and age at illness onset on a number of clinical and cognitive manifestations in 438 outpatients with major depressive disorder aged >60 years, treated with venlafaxine for 12 weeks. When compared to the EOD group, patients with LOD were older ( P  < 0...
March 22, 2023: International Clinical Psychopharmacology
https://read.qxmd.com/read/36947416/efficacy-and-safety-profiles-of-mood-stabilizers-and-antipsychotics-for-bipolar-depression-a-systematic-review
#6
JOURNAL ARTICLE
Luyao Cai, Guanjie Chen, Haichen Yang, Yuanhan Bai
The whole picture of psychotropics for bipolar depression (BPD) remains unclear. This review compares the differences in efficacy and safety profiles among common psychotropics for BPD. MEDLINE, EMBASE, and PsycINFO were searched for proper studies. The changes in the depressive rating scale, remission/response rates, nervous system adverse events (NSAEs), gastrointestinal adverse events (GIAEs), metabolic parameters, and prolactin were compared between medication and placebo or among medications with the Cohen's d or number needed to treat/harm...
March 13, 2023: International Clinical Psychopharmacology
https://read.qxmd.com/read/36947411/in-search-of-clinical-targets-for-suicide-prevention-in-major-depressive-disorder
#7
JOURNAL ARTICLE
Paolo Olgiati, Alessandro Serretti
No abstract text is available yet for this article.
March 13, 2023: International Clinical Psychopharmacology
https://read.qxmd.com/read/36947405/more-must-be-done-to-reduce-cardiovascular-risk-for-patients-on-antipsychotic-medications
#8
JOURNAL ARTICLE
Emanuele F Osimo, Benjamin I Perry, Graham K Murray
No abstract text is available yet for this article.
March 6, 2023: International Clinical Psychopharmacology
https://read.qxmd.com/read/36866853/sleep-disturbance-in-schizophrenia-spectrum-disorders-more-than-just-a-symptom
#9
JOURNAL ARTICLE
Fabio Ferrarelli
Sleep disturbance is commonly reported in patients with schizophrenia spectrum disorder (SSD) in the clinical setting. Sleep features can be assessed subjectively, with self-report sleep questionnaires, and objectively with actigraphy and electroencephalogram recordings. Traditionally, electroencephalogram studies have focused on sleep architecture. More recently, numerous studies have investigated alterations in sleep-specific rhythms, including electroencephalogram oscillations, such as sleep spindles and slow waves, in patients with SSD compared with control subjects...
March 6, 2023: International Clinical Psychopharmacology
https://read.qxmd.com/read/36866848/the-importance-of-early-and-proactive-use-of-long-acting-injectable-antipsychotics-in-the-management-of-schizophrenia
#10
JOURNAL ARTICLE
Hiroyoshi Takeuchi
No abstract text is available yet for this article.
March 6, 2023: International Clinical Psychopharmacology
https://read.qxmd.com/read/36947414/interplay-of-environmental-and-clinical-factors-in-psychiatric-disorders
#11
JOURNAL ARTICLE
Alessandro Serretti
No abstract text is available yet for this article.
May 1, 2023: International Clinical Psychopharmacology
https://read.qxmd.com/read/36630183/clinical-experiences-with-intranasal-esketamine-for-major-depressive-disorder-resistant-to-treatment-and-with-a-psychiatric-emergency-case-presentations
#12
JOURNAL ARTICLE
Maurizio Pompili, Giuseppe Sarli, Denise Erbuto, Giovanni Manfredi, Anna Comparelli
Recently, esketamine became availableas an intranasal formulation, proposed for treatment-resistant depression (TRD). Three cases of TRD are presented, two with features of a psychiatric emergency. The first case is a 35-year-old man with MDD onset at the age of 27 years, with five previous failed therapies. The second patient is a middle-aged man with a 21-year MDD onset and six previous antidepressant treatments discontinued for poor therapeutic effects and tolerability. He also presented suicidal ideation with intent and a history of a failed suicide attempt by self-cutting his forearms...
May 1, 2023: International Clinical Psychopharmacology
https://read.qxmd.com/read/36719340/on-the-benefits-of-therapeutic-drug-monitoring-for-patients-undergoing-treatment-with-antipsychotic-agents
#13
JOURNAL ARTICLE
Laura Mercolini, Michele Protti, Roberto Mandrioli
No abstract text is available yet for this article.
March 1, 2023: International Clinical Psychopharmacology
https://read.qxmd.com/read/36719339/occurrence-of-involuntary-movements-after-prolonged-misuse-of-zolpidem-a-case-report
#14
JOURNAL ARTICLE
Sara Ricciardulli, Lorenzo Lattanzi, Margherita Barbuti, Roberto Ceravolo, Giulio Perugi
Zolpidem is a non-benzodiazepine agent used for short-term treatment of insomnia. Several cases of dependence and withdrawal from zolpidem are reported in the literature. Furthermore, involuntary movements after prolonged zolpidem misuse have been described. In this case report, a 69-year-old Italian woman with no history of diagnosed psychiatric or neurologic diseases developed uncontrolled movements and a depressive-anxious syndrome after twelve-year zolpidem misuse. The underlying mechanisms of involuntary movements occurring after long-term zolpidem intake are unknown; yet, we suggest that zolpidem might induce an increase in dopamine release through inhibition of gamma-aminobutyric acid neurons tonically suppressing dopamine cells...
March 1, 2023: International Clinical Psychopharmacology
https://read.qxmd.com/read/36719338/dopamine-supersensitivity-psychosis-and-delay-of-clozapine-treatment-in-patients-with-treatment-resistant-schizophrenia
#15
JOURNAL ARTICLE
Yuto Masumo, Nobuhisa Kanahara, Masanobu Kogure, Fumiaki Yamasaki, Yusuke Nakata, Masaomi Iyo
Both the underutilization of clozapine and treatment resistance of patients to clozapine are serious problems worldwide. Identifying clinical markers predicting response to clozapine would help clinicians more effectively utilize clozapine treatment. The present study retrospectively assessed dopamine supersensitivity psychosis (DSP) in addition to other measures such as age at disease onset and delay of clozapine introduction for a total of 47 treatment-resistant schizophrenia (TRS) patients. The response to clozapine was judged with CGI-C at 1 and 2 years from clozapine introduction...
March 1, 2023: International Clinical Psychopharmacology
https://read.qxmd.com/read/36719337/pharmacologic-treatment-of-depression-in-alzheimer-s-disease
#16
REVIEW
Robert Haussmann, Markus Donix
Major depressive disorder and Alzheimer's disease are common among older people, frequently co-occur and severely impact the quality of life. Unfortunately, data on the efficacy of pharmacologic treatment of depressive symptoms in patients with the neurodegenerative disease remain inconclusive. The heterogeneity of treatment study designs, from varying diagnostic specificity to diverse outcome measures, contributes to conflicting evidence across single trials and meta-analyses. In this literature review, we focus on commercially available products for antidepressant treatment in demented individuals and show how insights from randomized controlled trials could still guide and be aligned with common clinical practice...
March 1, 2023: International Clinical Psychopharmacology
https://read.qxmd.com/read/36719336/an-investigation-into-the-association-between-suicide-mortality-rate-and-lithium-levels-in-potable-water-a-review-study
#17
JOURNAL ARTICLE
Abdolmajid Fadaei
This study aimed to investigate the association between lithium levels in potable water and suicide mortality rates in the total inhabitants. We systematically searched Embase, PubMed/MEDLINE, Scopus, PubMed Central (PMC), Google Scholar databases, as well as medRxiv using the following keywords: drinking water, lithium, standardized mortality ratio (SMR), tap water, suicide, and ground water. Pearson regression analysis was used to test an association between variables with 95% confidence interval (CI). A value of P < 0...
March 1, 2023: International Clinical Psychopharmacology
https://read.qxmd.com/read/36719335/the-challenge-of-managing-difficult-to-treat-psychiatric-conditions
#18
JOURNAL ARTICLE
Alessandro Serretti
No abstract text is available yet for this article.
March 1, 2023: International Clinical Psychopharmacology
https://read.qxmd.com/read/36853797/frequency-risk-factors-and-impacts-on-quality-of-life-of-the-restless-legs-syndrome-and-side-effects-among-antidepressant-users-in-a-tertiary-hospital-an-observational-cross-sectional-study
#19
JOURNAL ARTICLE
Hatice Cetin Erdem, Huseyin Kara, Ozgen Ozcelik, Levent Donmez, Mehmet Eryilmaz, Gul Ozbey
Restless leg syndrome (RLS) is a common but underestimated sensorimotor disorder that significantly affects the quality of life (QoL) which can be induced by antidepressants. This study aims to investigate the frequency and potential risk factors of RLS and side effects in selective serotonin reuptake inhibitors/serotonin and noradrenaline reuptake inhibitors (SSRI/SNRI) users. This cross-sectional study included 198 outpatients who received SSRI/SNRI for 4-8 weeks. Clinical evaluation was performed using the International Restless Leg Syndrome Study Group rating scale for RLS, Udvalg for Kliniske Undersøgelser side effects rating scale, and a short form 36 (SF-36) questionnaire for QoL...
February 27, 2023: International Clinical Psychopharmacology
https://read.qxmd.com/read/36853754/clinical-correlates-and-prognostic-implications-of-severe-suicidal-ideation-in-major-depressive-disorder
#20
JOURNAL ARTICLE
Paolo Olgiati, Giuseppe Fanelli, Alessandro Serretti
Suicidal ideation (SI) is a risk factor for suicidal behaviour. To ascertain the clinical correlates and prognostic impact of severe SI, we analysed 249 outpatients with major depressive disorder (MDD) and suicidal thoughts included in the COmbining Medications to Enhance Depression outcome (CO-MED) trial. Patients with severe SI (36%) were younger at disease onset (P = 0.0033), more severely depressed (P = 0.0029), had more lifetime suicidal behaviour (P < 0.0001) and psychiatric comorbidities (panic disorder: P = 0...
February 27, 2023: International Clinical Psychopharmacology
journal
journal
29324
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.